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The University of California, San Francisco congenital heart defects. Most cases of congenital heart
disease are believed to be due to complex interactionsSan Francisco, California 94143
between genetic and environmental factors, but about
3% of cardiac malformations show classic Mendelian
inheritance [18]. Among the genes shown to be respon-Summary
sible for cardiac malformations is JAG1, which encodes
a ligand for the Notch signaling pathway. In humans,Congenital malformations of the heart and circulatory
haploinsufficiency for JAG1 causes Alagille syndrome,system are the most common type of human birth
which affects development of the heart, arteries, liver,defect. Recent studies have implicated the Notch sig-
eyes, and limbs, and missense mutations can lead tonaling pathway in human cardiac development by
isolated congenital heart defects, such as pulmonic ste-demonstrating abnormalities of the JAG1 gene as the
nosis and tetralogy of Fallot [1–4]. In the mouse, animalsbasis for Alagille syndrome and some cases of isolated
that are doubly heterozygous for mutations of Jag1 andtetralogy of Fallot or pulmonic stenosis [1–4]. How the
Notch2 recapitulate the cardiac (and other) defects ofNotch pathway acts in cardiac development remains
Alagille syndrome, and homozygous deletion of Jag1unknown, but the Hey family of basic helix-loop-helix
leads to defective vascular remodeling and early embry-(bHLH) transcription factors are candidates for medi-
onic lethality [20, 21]. While the phenotypes of Jag1ating Notch signaling in the developing cardiovascular
and Notch2 establish an important role for the Notchsystem [5–15]. Here, we use gene targeting to deter-
pathway during mammalian cardiac development, it re-mine the developmental functions of mouse Hey2, a
mains unknown what other genes of the Notch pathwayHey family member that is expressed during the em-
are required for heart development.bryonic development of the heart, arteries, and other
bHLH genes regulate cell fate specification and differ-organs. Homozygotes for the Hey2 mutant allele dis-
entiation in numerous developmental contexts [22–24],play a spectrum of cardiac malformations including
and the Hey family of bHLH genes (also referred to asventricular septal defects, tetralogy of Fallot, and tri-
HRT, HESR, CHF, Gridlock, or HERP) [5–15] is mostcuspid atresia, defects that resemble those associ-
closely related to the Hairy/Enhancer of Split (HES) fam-ated with mutations of human JAG1. These results
ily, many of which mediate transcriptional repression inestablish Hey2 as an important regulator of cardiac
response to Notch signaling [25]. Although divergentmorphogenesis and suggest a role for Hey2 in mediat-
enough to form a separate class of bHLH proteins, Heying or modulating Notch signaling in the developing
proteins contain three regions similar to conserved do-heart.
mains of HES proteins: the bHLH domain that mediates
protein dimerization and sequence specific DNA bind-
Results and Discussion ing, as well as the Orange domain and the YXXW motif,
whose cognate domains in HES proteins are believed
During mammalian cardiac morphogenesis, multiple cell to mediate transcriptional repression [25], and the Hey2
types work together to produce a four-chambered heart protein has been shown to repress transcription [8, 9,
with separate pulmonary and systemic circulations. This 14]. Hey genes are expressed in the developing cardio-
process is thought to be regulated by numerous genes, vascular system, and Hey2 is a direct target of Notch
a handful of which have been defined [16], and dis- signaling in cultured arterial smooth muscle cells [15],
rupting this process can lead to congenital malforma- suggesting that Hey2 may act as a transcriptional re-
tions of the heart, one of the most common and serious pressor downstream of Notch signaling in the cardiovas-
forms of human birth defects. Among the most frequent cular system. In zebrafish embryos, a regulatory path-
malformations are ventricular septal defect (leading to way involving Notch signaling and expression of
an abnormal communication between the right and left gridlock, the zebrafish homolog of Hey2, has been
ventricles) (25%–30% of all lesions), atrial septal defect shown to regulate arterial versus venous differentiation
(leading to an abnormal communication between the [26], and a mutation in gridlock leads to a localized
right and left atria) (6%–8%), pulmonic stenosis (an ab- defect of the aorta that resembles human coarctation
normal constriction that impairs blood flow from the of the aorta [10, 27].
right ventricle into the pulmonary circulation) (5%–7%), To determine the developmental function of Hey2 in
tricuspid atresia or failure of the tricuspid valve to form vivo, we have mutated Hey2 using targeted mutagenesis
in embryonic stem cells. Genomic clones from mouse
Hey2 were isolated from a 129/SVJ library (a gift from3 Correspondence: m-ustet@uchicago.edu
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Figure 1. Construction and Expression of a Targeted Mutation in Mouse Hey2
(A) The targeting vector is shown at the top, the normal genomic locus is shown in the middle panel, and the targeted allele is shown at the
bottom. The 5 homology arm is a BstXI fragment that extends within the first exon and is fused in frame to lacZ. The 3 homology arm
extends from a SpeI site within the third exon to a Sau3A1 site within the third intron. A homologous recombination event is predicted to
completely delete intron 1, exon 2, and intron 2 and to delete parts of exon 1 and 3. The locations of the 5 and 3 external probes used for
Southern blot screening of ES cells are shown underneath the targeted allele. B, BstXI; E, EcoRI; N, NotI; P, PstI; Pv, PvuII; Sp, Spe I; Sa,
Sau3A.
(B) Genotyping of Hey2 mutant animals by PCR using mutant and wild-type specific primers. Lanes: M, Molecular weight markers; 1, wild-
type; 2, heterozygote; 3, homozygous mutant.
(C–F) Embryos were histochemically stained for lacZ activity using the Xgal reaction. (C) An embryo at E9.0, showing lacZ activity in the
primitive ventricle (V), outflow tract (OT), and branchial arches (Br). (D) At E12.5, the developing left and right ventricles (LV and RV) are strongly
stained. Weaker staining is seen in the outflow tract, ductus arteriosus (DA), and aorta (Ao). (E) Dorsal view after dissection of the heart and
lungs at E13.5, showing strong labeling of the aorta and of the pulmonary arteries (PA) as they branch within the lungs (Lu). (F) Left lateral
view of the heart at E15, showing strong lacZ expression within the left ventricle (LV) but no labeling of the left atrium (LA).
G. Martin) using a human Hey2 cDNA probe (IMAGE sion similar to that reported for endogenous Hey2 [6–8].
In particular, expression within the embryonic heart wasclone 531909) [28]. In the targeting vector, lacZ was
fused in frame to codon 19 in the first exon of Hey2, predominantly within the developing ventricles, and ex-
pression was also observed within developing arteriesleading to a predicted null allele (Hey2lacZ) that encodes
a Hey2-lacZ fusion protein lacking the basic helix-loop- (Figures 1C–1F). Heart and arterial expression persisted
postnatally (data not shown). Reporter gene expressionhelix, Orange, and YXXW domains (Figure 1). A single
homologous recombinant was identified among 192 ES did not completely recapitulate Hey2 expression, as no
lacZ activity has been observed in developing cerebel-cell clones and was used to create chimeric mice by
blastocyst injection. lum (data not shown).
Genotyping of the progeny of heterozygous inter-Heterozygous Hey2lacZ/ animals were stained for ex-
pression of the lacZ reporter gene, and showed expres- crosses demonstrated that Hey2lacZ/lacZ animals were un-
Table 1. Genotypes of Progeny from Hey2/lacZ Heterozygous Intercrosses
Stage analyzed Hey2/ (%) Hey2/lacZ (%) Hey2lacZ/lacZ (%) Total P value
Embryonic litters 64 (23) 142 (50) 78 (27) 284 0.5
P0–P1 45 (31) 73 (50) 28 (19) 146 0.14
Weaning 52 (36) 87 (60) 5 (3) 144 9.6  109
Litters were collected in utero during the second half of embryonic development, on postnatal day 0 (P0) or P1, or at weaning (3–4 weeks
postnatal), and Hey2 genotype was determined by PCR. 2 analysis was used to determine the probability that the genotype frequency differed
from the expected Mendelian ratio due simply to chance.
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derrepresented at weaning (Table 1). Whereas genotype
frequencies of litters collected in utero or shortly after
birth approached the expected Mendelian ratios, at
weaning only about 3% of the progeny were Hey2lacZ/lacZ
(P value 9.6  109).
Most of the Hey2lacZ/lacZ progeny died within the first
ten days after birth. Hey2lacZ/mice were morphologically
indistinguishable from wild-type animals, but necropsy
of homozygous mutant pups showed consistent malfor-
mations of the heart. Typically, the hearts were enlarged
with an abnormal pear-shaped configuration, and ani-
mals that survived into the second postnatal week dis-
played right and left ventricular hypertrophy (Figure 2).
On sectioning, the most frequent malformation ob-
served was a membranous ventricular septal defect with
overriding aorta (Figures 2C and 2D). This defect was
seen in all Hey2lacZ/lacZ progeny examined in the late pre-
natal and early postnatal period (n  20). In addition to
the defect of the membranous portion of the interventric-
ular septum, some animals showed a defect of the mus-
cular septum as well (Figures 2C and 2D). Ventricular
septal defects have also been observed in Hey2 mutant
animals independently (M.T. Chin, personal communi-
cation).
Ventricular septal defects often lead to hemodynamic
compromise due to shunting of blood between the pul-
monary and systemic circulations. To investigate the
potential for pathological shunting of blood flow, the
right atria of postnatal hearts were infused with a blue
methacrylate resin to produce casts of the cardiac lu-
men (Figures 2E–2H). In wild-type and heterozygous ani-
mals, the dye passed from the right atrium into the right
ventricle and out through the pulmonary artery (Figures
2E and 2G). In Hey2lacZ/lacZ animals, the dye passed from
the right atrium not only into the right ventricle, but
also crossed the ventricular septal defect to fill the left
ventricle. The dye then flowed into the aorta and pulmo-
nary artery (Figures 2F and 2H). These results are consis-
tent with the observed morphologic defects leading to
abnormal shunting of blood flow.
The pulmonic outflow tract was carefully examined
in fifteen Hey2lacZ/lacZ hearts, and six of these showed
pulmonic stenosis in addition to the ventricular septal
defect and overriding aorta (Figure 3). This constellation
of defects, along with the secondary hypertrophy ob-
Figure 2. Ventricular Septal Defects and Right Ventricular Hypertro- served in older animals, is similar to human tetralogy of
phy in Hey2lacZ/lacZ Mutant Hearts Fallot. We also observed a defect of the interatrial sep-
(A–D) Whole mount preparations of hearts at postnatal day 7 (P7). tum and abnormalities of the tricuspid valve, ranging
(A and C) Control animal. (B and D) Hey2lacZ/lacZ homozygote. (A and
from stenosis to complete absence, or atresia, in sixC) Control heart at postnatal day 7 after sectioning to reveal the
of fifteen Hey2lacZ/lacZ hearts. Figure 4 shows histologicfour cardiac chambers and an intact interventricular septum (IVS).
Ao, aorta; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right sections from a homozygote and a littermate control
ventricle. (B and D) Adjacent sections of a Hey2lacZ/lacZ homozygous that were examined on postnatal day 2 (P2). In addition
heart reveal an abnormal ventricular shape, a membranous ventricu-
lar septal defect (VSD) with an overriding aorta, and a muscular
ventricular septal defect more inferiorly. There is hypertrophy of the
right and left ventricular myocardium as indicated by increased
left atrium, left ventricle, or aorta. The ductus arteriosus (DA) isthickness of the ventricular walls, and concomitant atrial enlarge-
closed.ment. Scale bars: 0.5 mm.
(F and H) The Hey2lacZ/lacZ homozygous mutant heart has an abnormal(E and F) Whole mount preparations of hearts injected with blue
shape, and dye from the right atrium flows not only into the rightmethacrylate polymer on P2.
ventricle and pulmonary artery, but also crosses the ventricular(G and H) Schematic representations of hearts shown in (E) and (F),
septal defects to enter the left ventricle and aorta. The ductus arteri-respectively.
osus is closed. Blue arrows, path of normal blood flow; red arrows,(E and G) In the control heart, dye fills the right atrium and flows
abnormal circulation across ventricular septal defects.into the right ventricle and pulmonary artery (PA). No dye enters the
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Figure 4. Tricuspid Atresia in the Hey2lacZ/lacZ HeartFigure 3. Pulmonic Stenosis in Hey2lacZ/lacZ Mutants
Histologic sections from the heart of Hey2lacZ/lacZ homozygotes (B,(A and B) Whole mount preparation of hearts at P9. (A) The control
D, and F) and Hey2lacZ/ littermate controls (A, C, and E). (A–D) P2;heart shows a normal caliber pulmonary artery (PA) and aorta (Ao).
(E–F) E13.5.(B) A Hey2lacZ/lacZ homozygous littermate of the animal in (A) shows
(A) A section at the level of the atrioventricular communication in anarrowing of the pulmonary artery.
control heart demonstrates the tricuspid valve (TV) and mitral valve(C and D) Histologic sections of the pulmonic valve on embryonic
(MV), as well as an intact interatrial septum (IAS).day 15.5 (E15.5). (C) The pulmonic valve of a control embryo on
(B) In the mutant, the tricuspid valve is absent, and an atrial septalE15.5 shows the lumen (*) between the leaflets of the valve. (D) The
defect (ASD) allows shunting of blood from the right atrium to thepulmonic valve of a homozygous Hey2lacZ/lacZ littermate of the embryo
left atrium.shown in (C) demonstrates pulmonic stenosis. The leaflets of the
(C) A section at the level of the aortic valve shows the intact interven-pulmonic valve are fused, and the lumen (*) is narrow.
tricular septum (IVS) in the control.
(D) A comparable section in the mutant demonstrates a large ventric-
to having features of tetralogy of Fallot—such as a large ular septal defect (*) directly below the root of the aorta (Ao).
(E) Transverse section through the heart of a control embryo onventricular septal defect with an overriding aorta (Figure
E13.5. At this stage, the interventricular septum completes closure4D)—the heart of the homozygote also shows an atrial
to separate the right ventricle from the left ventricle, the tricuspidseptal defect and complete atresia of the tricuspid valve
valve is forming from endocardial cushion (EC) tissue to connect(Figure 4B). the right atrium (RA) to the right ventricle, and the mitral valve is
The valves and septa that separate the chambers of forming between the left atrium (LA) and left ventricle.
the heart are formed by E14, the fourteenth day of em- (F) A homozygous Hey2lacZ/lacZ littermate of the embryo shown in (A).
The membranous portion of the interventricular septum has notbryonic development [29]. To assess the effect of Hey2
formed, leaving a communication between the right ventricle anddeficiency at the time of cardiac chamber formation, we
left ventricle, and no tricuspid valve is forming from the endocardialanalyzed the hearts of developing embryos between
cushion (EC), preventing the right atrium from directly communicat-E13.5 and E15.5. At these stages, we found a similar ing with the right ventricle. The right atrium communicates with the
spectrum of cardiac malformations as observed in post- left atrium, and a developing mitral valve is seen between the left
natal animals. In particular, Hey2lacZ/lacZ fetuses showed atrium and left ventricle.
defects of the interventricular septum (Figures 4E and
4F), sometimes in combination with narrowing of the
pulmonic outflow tract (Figures 3C and 3D) or with de- Interestingly, mutations of the human Notch ligand
JAG1 have previously been shown to cause tetralogyfects of the tricuspid valve (Figures 4E and 4F).
of Fallot, pulmonic stenosis, and other cardiac malfor-
mations in isolation and as part of Alagille syndromeConclusions
Our results establish that Hey2 plays an important role in [1–4], indicating that altered Notch signaling can lead
to cardiac malformations similar to those we observe incardiac morphogenesis. Animals lacking Hey2 develop
lethal malformations of the heart that resemble common Hey2lacZ/lacZ mutant mice. Taken in the context of previous
studies linking Hey2 to the Notch signaling pathway [9,human congenital heart defects, including ventricular
septal defects, tetralogy of Fallot, and tricuspid atresia. 15, 30, 31], the similarities in the cardiac defects caused
by mutations in mouse Hey2 and human JAG1 suggestApproximately 25%–30% of children with cardiac anom-
alies have ventricular septal defects, and about 5%–7% that Hey2 may act in heart development by mediating or
regulating Notch signaling. Cardiac development resultshave tetralogy of Fallot [17–19], and human HEY2 now
becomes a candidate gene for involvement in these from complex morphogenetic processes involving the
myocardium, the endocardial cushions, and the cardiacmalformations.
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